logo
Select company
Select metric
-25.51%EBIT Margin
VS
Market
20
Sector
52
Industry
77
History
71
$ 8.24Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information

Ticker

FENC

Company Name

FENNEC PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FENNEC PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FENC - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -8.49M-25.51%$ 33.3M
3/31/2025$ -10.45M-33.79%$ 30.91M
12/31/2024$ 4M8.41%$ 47.54M
9/30/2024$ 3.79M7.68%$ 49.35M
6/30/2024$ 7.49M15.32%$ 48.89M
3/31/2024$ 7.38M16.42%$ 44.95M
12/31/2023$ -12.65M-59.53%$ 21.25M
9/30/2023$ -17M-130.23%$ 13.05M
6/30/2023$ -23.96M-366.47%$ 6.54M
3/31/2023$ -24.35M-758.16%$ 3.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, FENNEC PHARMACEUTICALS INC's average EBIT % has been -2986.39%.
  • The median EBIT % for FENNEC PHARMACEUTICALS INC during this period was -130.23%
  • FENNEC PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at 16.42%.
  • The lowest EBIT % recorded by FENNEC PHARMACEUTICALS INC in the same timeframe -11185.88%

FENNEC PHARMACEUTICALS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CCCC : C4 THERAPEUTICS INC -325.5%VYGR : VOYAGER THERAPEUTICS INC -347.02%EDIT : EDITAS MEDICINE INC -622.5%OABI : OMNIAB INC -296.89%FHTX : FOGHORN THERAPEUTICS INC -311.9%SCPH : SCPHARMACEUTICALS INC -171.3%STXS : STEREOTAXIS INC -73.43%LCTX : LINEAGE CELL THERAPEUTICS INC -374.84%MGX : METAGENOMI INC -267.38%MXCT : MAXCYTE INC -125.22%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for FENNEC PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -18.48M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

FENC - EBIT Margin, Last 5 years

-11185.88%

Minimum

Mar 31, 2021

16.42%

Maximum

Mar 31, 2024

-2986.39%

Average

-130.23%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%